Research Roadmap

Once approval from the review committee is obtained, the study can be registered in a trial register. While registration is voluntary, it is important to note that an increasing number of medical and biomedical journals require registration in a publicly accessible registry approved by the World Health Organization (WHO) as a condition for publication.

For clinial trials involving medicinal products, this requirement is automatically fulfilled by submitting the study in CTIS and completing the associated form. The relevant information is then published in the EU Clinical Trials Register.

For all other research subject to the WMO, MDR or IVDR, the researcher is responsible for registering the study in a WHO-approved trial register (free of charge). The WHO website provides a list of available international, European and national registers that meet the registration requirements.
At Amsterdam UMC, the most commonly used registers are ClinicalTrials.gov, ISRCTN Registry and the Overview of Medical Research in the Netherlands (OMON).

Important: registration in a trial register must be completed before the first particpant signs the informed consent form.